These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2656396)

  • 1. Functioning of a hybrid BRP-beta-lactamase protein in the release of cloacin DF13 and lysis of Escherichia coli cells.
    Luirink J; de Jong J; van Putten AJ; de Graaf FK; Oudega B
    FEMS Microbiol Lett; 1989 Mar; 49(1):25-31. PubMed ID: 2656396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a mutation preventing lipid modification on localization of the pCloDF13-encoded bacteriocin release protein and on release of cloacin DF13.
    Luirink J; Hayashi S; Wu HC; Kater MM; de Graaf FK; Oudega B
    J Bacteriol; 1988 Sep; 170(9):4153-60. PubMed ID: 3045086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pCloDF13-encoded bacteriocin release proteins with shortened carboxyl-terminal segments are lipid modified and processed and function in release of cloacin DF13 and apparent host cell lysis.
    Luirink J; Clark DM; Ras J; Verschoor EJ; Stegehuis F; de Graaf FK; Oudega B
    J Bacteriol; 1989 May; 171(5):2673-9. PubMed ID: 2651413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uncoupling of synthesis and release of cloacin DF13 and its immunity protein by Escherichia coli.
    Luirink J; de Graaf FK; Oudega B
    Mol Gen Genet; 1987 Jan; 206(1):126-32. PubMed ID: 3553860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stable BRP signal peptide causes lethality but is unable to provoke the translocation of cloacin DF13 across the cytoplasmic membrane of Escherichia coli.
    van der Wal FJ; Oudega B; Kater MM; ten Hagen-Jongman CM; de Graaf FK; Luirink J
    Mol Microbiol; 1992 Aug; 6(16):2309-18. PubMed ID: 1406270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functioning of the stable signal peptide of the pCloDF13-encoded bacteriocin release protein.
    Luirink J; Duim B; de Gier JW; Oudega B
    Mol Microbiol; 1991 Feb; 5(2):393-9. PubMed ID: 2041475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of bacteriocin release protein (BRP)-mediated protein release by Escherichia coli: random mutagenesis of the pCloDF13-derived BRP gene to uncouple lethality and quasi-lysis from protein release.
    van der Wal FJ; Koningstein G; ten Hagen CM; Oudega B; Luirink J
    Appl Environ Microbiol; 1998 Feb; 64(2):392-8. PubMed ID: 9464372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The stable bacteriocin release protein signal peptide, expressed as a separate entity, functions in the release of cloacin DF13.
    van der Wal FJ; ten Hagen CM; Oudega B; Luirink J
    FEMS Microbiol Lett; 1995 Sep; 131(2):173-7. PubMed ID: 7557327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning, expression and release of native and mutant cloacin DF13 immunity protein.
    Verschoor EJ; Luirink J; De Waard S; De Graaf FK; Oudega B
    Antonie Van Leeuwenhoek; 1989 Apr; 55(4):325-40. PubMed ID: 2658798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability and function of the signal peptide of the pCloDF13-derived bacteriocin release protein.
    van der Wal FJ; Valent QA; ten Hagen-Jongman CM; de Graaf FK; Oudega B; Luirink J
    Microbiology (Reading); 1994 Feb; 140 ( Pt 2)():369-78. PubMed ID: 8180702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the pCloDF13 encoded bacteriocin release protein or its stable signal peptide causes early effects on protein biosynthesis and Mg2+ transport.
    Stegehuis F; van der Wal FJ; Luirink J; Oudega B
    Antonie Van Leeuwenhoek; 1995; 67(3):255-60. PubMed ID: 7778894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification, processing, and subcellular localization in Escherichia coli of the pCloDF13-encoded bacteriocin release protein fused to the mature portion of beta-lactamase.
    Luirink J; Watanabe T; Wu HC; Stegehuis F; de Graaf FK; Oudega B
    J Bacteriol; 1987 May; 169(5):2245-50. PubMed ID: 3553160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of divalent cations and of phospholipase A activity on excretion of cloacin DF13 and lysis of host cells.
    Luirink J; van der Sande C; Tommassen J; Veltkamp E; De Graaf FK; Oudega B
    J Gen Microbiol; 1986 Mar; 132(3):825-34. PubMed ID: 3016150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A lipoprotein signal peptide plus a cysteine residue at the amino-terminal end of the periplasmic protein beta-lactamase is sufficient for its lipid modification, processing and membrane localization in Escherichia coli.
    Oudega B; Clark D; Stegehuis F; Majoor MJ; Luirink J
    FEMS Microbiol Lett; 1993 Apr; 108(3):353-9. PubMed ID: 8514122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Escherichia coli SecB, SecA, and SecY proteins are required for expression and membrane insertion of the bacteriocin release protein, a small lipoprotein.
    Oudega B; Mol O; van Ulsen P; Stegehuis F; van der Wal FJ; Luirink J
    J Bacteriol; 1993 Mar; 175(5):1543-7. PubMed ID: 8444816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of Escherichia coli to cloacin DF13 involves the major outer membrane protein OmpF.
    Wooldridge KG; Williams PH
    J Bacteriol; 1991 Apr; 173(8):2420-4. PubMed ID: 2013565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the carboxy-terminal half of cloacin destabilize the protein and prevent its export by Escherichia coli.
    van Putten AJ; Stegehuis F; van Bergen en Henegouwen PM; De Graaf FK; Oudega B
    Mol Microbiol; 1988 Sep; 2(5):553-62. PubMed ID: 3054421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of tol genes in cloacin DF13 susceptibility of Escherichia coli K-12 strains expressing the cloacin DF13-aerobactin receptor IutA.
    Thomas JA; Valvano MA
    J Bacteriol; 1993 Jan; 175(2):548-52. PubMed ID: 8419302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein H encoded by plasmid CloDF13 is involved in excretion of cloacin DF13.
    Oudega B; Stegehuis F; van Tiel-Menkveld GJ; de Graaf FK
    J Bacteriol; 1982 Jun; 150(3):1115-21. PubMed ID: 6281236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of cloacin DF13 by susceptible cells: removal of immunity protein and fragmentation of cloacin molecules.
    Krone WJ; de Vries P; Koningstein G; de Jonge AJ; de Graaf FK; Oudega B
    J Bacteriol; 1986 Apr; 166(1):260-8. PubMed ID: 2420782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.